The flavoprotein MrsD catalyzes the oxidative decarboxylation reaction involved in formation of the peptidoglycan biosynthesis inhibitor mersacidin

被引:67
作者
Majer, F
Schmid, DG
Altena, K
Bierbaum, G
Kupke, T
机构
[1] Univ Tubingen, Lehrstuhl Mikrobielle Genet, Verfugungsgebaude, D-72076 Tubingen, Germany
[2] Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany
[3] Univ Bonn, Inst Med Mikrobiol & Immunol, D-53105 Bonn, Germany
关键词
D O I
10.1128/JB.184.5.1234-1243.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The lantibiotic mersacidin inhibits peptidoglycan biosynthesis by binding to the peptidoglycan precursor lipid II. Mersacidin contains an unsaturated thioether bridge, which is proposed to be synthesized by post-translational modifications of threonine residue +15 and the COOH-terminal cysteine residue of the mersacidin precursor peptide MrsA. We show that the flavoprotein MrsD catalyzes the oxidative decarboxylation of the COOH-terminal cysteine residue of MrsA to an aminoenethiol residue. MrsD belongs to the recently described family of homo-oligomeric flavin-containing Cys decarboxylases (i.e., the HFCD protein family). Members of this protein family include the bacterial Dfp proteins (which are involved in coenzyme A biosynthesis), eukaryotic salt tolerance proteins, and further oxidative decarboxylases such as EpiD. In contrast to EpiD and Dfp, MrsD is a FAD and not an FMN-dependent flavoprotein. HFCD enzymes are characterized by a conserved His residue which is part of the active site. Exchange of this His residue for Asn led to inactivation of MrsD. The lantibiotic-synthesizing enzymes EpiD and MrsD have different substrate specificities.
引用
收藏
页码:1234 / 1243
页数:10
相关论文
共 38 条
[1]   The X-ray structure of the FMN-binding protein AtHal3 provides the structural basis for the activity of a regulatory subunit involved in signal transduction [J].
Albert, A ;
Martínez-Ripoll, M ;
Espinosa-Ruiz, A ;
Yenush, L ;
Culiáñez-Macià, FA ;
Serrano, R .
STRUCTURE, 2000, 8 (09) :961-969
[2]   ELUCIDATION OF THE STRUCTURE OF EPIDERMIN, A RIBOSOMALLY SYNTHESIZED, TETRACYCLIC HETERODETIC POLYPEPTIDE ANTIBIOTIC [J].
ALLGAIER, H ;
JUNG, G ;
WERNER, RG ;
SCHNEIDER, U ;
ZAHNER, H .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1985, 24 (12) :1051-1053
[3]   Biosynthesis of the lantibiotic mersacidin: Organization of a type B lantibiotic gene cluster [J].
Altena, K ;
Guder, A ;
Cramer, C ;
Bierbaum, G .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2000, 66 (06) :2565-2571
[4]   Crystal structure of the peptidyl-cysteine decarboxylase EpiD complexed with a pentapeptide substrate [J].
Blaesse, M ;
Kupke, T ;
Huber, R ;
Steinbacher, S .
EMBO JOURNAL, 2000, 19 (23) :6299-6310
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation [J].
Brotz, H ;
Bierbaum, G ;
Reynolds, PE ;
Sahl, HG .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 246 (01) :193-199
[7]   The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II [J].
Brötz, H ;
Bierbaum, G ;
Leopold, K ;
Reynolds, PE ;
Sahl, HG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (01) :154-160
[8]   MERSACIDIN, A NEW ANTIBIOTIC FROM BACILLUS INVITRO AND INVIVO ANTIBACTERIAL ACTIVITY [J].
CHATTERJEE, S ;
CHATTERJEE, DK ;
JANI, RH ;
BLUMBACH, J ;
GANGULI, BN ;
KLESEL, N ;
LIMBERT, M ;
SEIBERT, G .
JOURNAL OF ANTIBIOTICS, 1992, 45 (06) :839-845
[9]   MERSACIDIN, A NEW ANTIBIOTIC FROM BACILLUS FERMENTATION, ISOLATION, PURIFICATION AND CHEMICAL CHARACTERIZATION [J].
CHATTERJEE, S ;
CHATTERJEE, S ;
LAD, SJ ;
PHANSALKAR, MS ;
RUPP, RH ;
GANGULI, BN ;
FEHLHABER, HW ;
KOGLER, H .
JOURNAL OF ANTIBIOTICS, 1992, 45 (06) :832-838
[10]  
Cormack B., 1991, CURRENT PROTOCOLS MO, V1, P851